MMSI — Merit Medical Systems, Inc. stock price, charts and financials

QT54Merit Medical Systems, Inc.

Merit Medical Systems, Inc. (NASDAQ: MMSI) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
85.82
+0.29+0.34%
MMSIQT54Merit Medical Systems, Inc.·NASDAQ
85.82+0.34%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E35.46EPS (ttm)2.42Insider Own5.69%Shs Outstand59.65MPerf Week9.62%
Market Cap5.12BForward P/E18.61EPS next Y4.61Insider Trans0.13%Shs Float58.24MPerf Month20.11%
Enterprise Value5.54BPEG6.17EPS next Q1.03Inst Own-Short Float5.91%Perf Quarter38.40%
Income146.00MP/S3.24EPS this Y77.78%Inst Trans-Short Ratio4.27Perf Half Y5.16%
Sales1.58BP/B3.05EPS next Y7.20%ROA5.08%Short Interest3.44MPerf YTD-2.63%
Book/sh28.16P/C11.40EPS next 5Y5.75%ROE9.07%52W High94.74 -9.42%Perf Year1.23%
Cash/sh7.53P/FCF21.27EPS past 3/5Y18.19% -ROIC5.76%52W Low59.74 43.66%Perf 3Y16.76%
Dividend Est.-EV/EBITDA21.46Sales past 3/5Y9.59% 9.46%Gross Margin49.52%Volatility4.78% 3.40%Perf 5Y32.99%
Dividend TTM-EV/Sales3.51EPS Y/Y TTM19.21%Oper. Margin12.72%ATR (14)2.74Perf 10Y295.30%
Dividend Ex-Date-Quick Ratio2.79Sales Y/Y TTM16.29%Profit Margin9.22%RSI (14)79.06Recom2.27
Dividend Gr. 3/5Y-Current Ratio4.20EPS Q/Q17.82%SMA2012.41%Beta0.48Target Price99.22
Payout0.00%Debt/Eq0.57Sales Q/Q9.42%SMA5021.69%Rel Volume1.66Prev Close85.53
Employees7,500LT Debt/Eq0.56EarningsOct 29SMA20012.83%Avg Volume860.47KPrice85.82
IPO DateMay 14, 1990Option/ShortYes / YesEPS/Sales Surpr.24.09% 3.36%Net Debt/EBITDA1.63Volume1,425,917Change0.34%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-31-26ReiteratedBarringtonOutperform$107$114
Jul-31-26ReiteratedCanaccord GenuityBuy$99$94
Jul-31-26ReiteratedRaymond JamesOutperform$83$100
Jul-31-26ReiteratedRobert W. Baird$89$98
Jul-31-26ReiteratedNeedhamBuy$105$101
Jul-31-26ReiteratedBTIGBuy$107$105
May-01-26ReiteratedRobert W. Baird$92$83
Apr-20-26ReiteratedCompass Point$109$107
Apr-17-26ReiteratedPiper SandlerOverweight$106$96
Feb-26-26DowngradeWells FargoOverweightEqual Weight$106$78
Latest News
Jul-31-26
Jul-30-26
Jul-29-26
Jul-28-26
Jul-20-26
Jul-15-26
Jul-09-26
Jul-08-26
Jul-02-26
Company

Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,5781,5151,3571,2571,1511,075964995883
Cost of Goods Sold Incl. D&A798778713673632589563562488
Gross Profit782737643584519485401432395
Selling, General and Administrative Excl. Other482455377374343336298327276
Research and Development999784837671586660
Other Operating Expense01272131747240
Operating Income2011841561248861-21559
Interest Expense-526311665101310
Unusual Expense
Non-Operating Income (Expense)-12132641-2-2-11
Net Income Before Taxes1951711501128354-13250
Income Taxes5042301885-3-38
Consolidated Net Income146128120947548-10542
Net Income From Continuing Operations107128120947548-10542
Net Income146128120947548-10542
EPS (Recurring)2.452.172.071.641.310.86-0.180.100.80
EPS (Basic, Before Extraordinaries)2.452.172.071.641.310.86-0.180.100.80
EPS (Diluted)2.422.132.031.621.290.84-0.180.100.78
EBITDA258332274229181155104119129
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio35.4641.3847.6546.8954.7474.17322.1971.55
Price To Sales Ratio3.263.434.133.503.503.253.171.733.29
Gross Margin49.5648.6547.3846.4645.0945.1241.6043.4244.73
Operating Margin12.7412.1511.509.867.655.67-0.211.516.68
Net Margin9.258.458.847.486.524.47-1.040.504.76
Shares Outstanding605958585756555552
Market Capitalization5,1495,2005,6104,4064,0253,4893,0531,7172,902
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$101.93$90.17$78.41$66.64$54.88 Close Price0.00M1.30M2.59M3.89M5.19MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Gunderson Thomas J.DirectorMay 20 '26Option Exercise52.1721,2501,108,61360,741May 21
Smith Christian AdamChief Commercial OfficerMay 11 '26Buy61.001,62699,1862,220May 13
Ward Lynne N.DirectorMay 07 '26Sale62.615,000313,0357,809May 11
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARYMay 07 '26Buy62.632,000125,2502,000May 11
Aronson Martha GoldbergPresident and CEOMay 06 '26Buy60.442,000120,88049,792May 07
Parra Raul Jr.CFO AND TREASURERMay 06 '26Buy61.011,50091,51558,843May 07
Voigt Michel J.CHIEF HUMAN RESOURCES OFFICERMay 05 '26Buy60.652,250136,4632,265May 07
Peterson Neil W.CHIEF OPERATING OFFICERJan 06 '26Option Exercise54.405,000272,00033,369Jan 08
Peterson Neil W.CHIEF OPERATING OFFICERJan 06 '26Sale90.005,000450,00028,369Jan 08
Lampropoulos Fred P.Executive ChairmanNov 25 '25Sale88.0410,000880,3771,019,955Nov 26
Lampropoulos Fred P.Executive ChairmanNov 21 '25Sale87.3125,0002,182,7501,029,955Nov 24
Lampropoulos Fred P.Executive ChairmanNov 20 '25Sale85.1320,0001,702,6501,054,955Nov 21
Lampropoulos Fred P.Executive ChairmanNov 18 '25Sale84.835,000424,1301,074,955Nov 20
Lampropoulos Fred P.President and CEOAug 29 '25Option Exercise55.73161,1518,980,9451,204,779Sep 03
Ward Lynne N.DirectorAug 22 '25Option Exercise34.463,000103,38015,809Aug 25
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.